AI Clinical Trial Accelerator Reshapes Drug Development
AI is revolutionizing clinical trials, accelerating drug development with 80-90% phase 1 success rates and reducing timelines dramatically. The market is projected to reach...
The ai stream tracks key shifts, competing narratives, and what the latest verified updates actually change.
814 results • page 64 / 136
AI is revolutionizing clinical trials, accelerating drug development with 80-90% phase 1 success rates and reducing timelines dramatically. The market is projected to reach...
New Zealand launches non-binding AI ethics framework for public sector, featuring five principles and six implementation pillars. The light-touch approach balances innovation...
Hollywood studios propose shifting from 3-year to 5-year labor contracts in exchange for $110M to stabilize union health plans. Key issues include AI protections, residuals,...
The EU AI Act implementation guidance outlines phased compliance requirements through 2030, with risk-based classification, business impacts, and community protections shaping...
Film industry labor negotiations stall as production declines 40%, impacting thousands of crew members. IATSE faces internal reforms while AI automation and studio mergers...
AI-designed drug candidates enter critical validation trials in 2025, with partnerships between pharma giants and AI companies accelerating discovery while reducing costs and...